The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC).
 
Bo Zhai
No Relationships to Disclose
 
Donghua Shi
No Relationships to Disclose
 
Huiping Gao
Employment - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Xingxing Qi
No Relationships to Disclose
 
Hua Jiang
Stock and Other Ownership Interests - CARsgen Therapeutics
Consulting or Advisory Role - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
 
Yuan Zhang
No Relationships to Disclose
 
Jiachang Chi
No Relationships to Disclose
 
Huaying Ruan
Employment - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Huamao Wang
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Qinhua Cindy Ru
Employment - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics
 
Zonghai Li
Employment - CARsgen Therapeutics
Leadership - CARsgen Therapeutics
Stock and Other Ownership Interests - CARsgen Therapeutics
Research Funding - CARsgen Therapeutics
Patents, Royalties, Other Intellectual Property - CARsgen Therapeutics
Travel, Accommodations, Expenses - CARsgen Therapeutics